Abstract
Background: Panic disorder (PD) has a strong genetic component showing high heritability rates and familial aggregation. Moreover, there is evidence for associations between parental PD and patterns of psychopathology. So far, little is known about possible endophenotypes representing premorbid vulnerability markers in high-risk subjects for PD. In the present study, we investigated saccadic eye movement (SEM) as an index of CNS inhibitory function in subjects at high risk for PD.
Methods: 132 healthy children at high and low familial risk for PD were included in the study. Basal SEM parameters were obtained using an electro-oculography (EOG) based system measuring peak saccadic eye velocity (pSEV), latency and accuracy. Moreover, with regard to self rating scales, state-trait-anxiety (STAI-C), childhood behavioral inhibition (CSRI), and anxiety sensitivity (CASI) were assessed. Results: There was a significant overall difference for basal SEM parameters across groups as revealed by MANCOVA (F7,118=2.184, p=.040). A significant influence was found for the covariate age, while gender and puberty status had no influence on SEM. High-risk (HR) subjects showed significantly lower pSEV. Moreover, levels of state and trait anxiety were higher in HR children (F1=5.429, p=.021). Discussion: In our sample, measurement of pSEV allowed discrimination between children at high and low risk for PD. Since these results argue for possible alterations of saccadic function in high risk subjects, differences in underlying neurobiological mechanisms might be discussed as a possible endophenotype of PD.Keywords: Saccadic eye movement, peak saccadic eye velocity, latency, accuracy, panic disorder, offspring at risk, GABA
Current Pharmaceutical Design
Title:Differences in Saccadic Eye Movements in Subjects at High and Low Risk for Panic Disorder
Volume: 18 Issue: 35
Author(s): Peter Zwanzger, Jacques Bradwejn, Julia Diemer, Roger W. Marshall and Diana Koszycki
Affiliation:
Keywords: Saccadic eye movement, peak saccadic eye velocity, latency, accuracy, panic disorder, offspring at risk, GABA
Abstract: Background: Panic disorder (PD) has a strong genetic component showing high heritability rates and familial aggregation. Moreover, there is evidence for associations between parental PD and patterns of psychopathology. So far, little is known about possible endophenotypes representing premorbid vulnerability markers in high-risk subjects for PD. In the present study, we investigated saccadic eye movement (SEM) as an index of CNS inhibitory function in subjects at high risk for PD.
Methods: 132 healthy children at high and low familial risk for PD were included in the study. Basal SEM parameters were obtained using an electro-oculography (EOG) based system measuring peak saccadic eye velocity (pSEV), latency and accuracy. Moreover, with regard to self rating scales, state-trait-anxiety (STAI-C), childhood behavioral inhibition (CSRI), and anxiety sensitivity (CASI) were assessed. Results: There was a significant overall difference for basal SEM parameters across groups as revealed by MANCOVA (F7,118=2.184, p=.040). A significant influence was found for the covariate age, while gender and puberty status had no influence on SEM. High-risk (HR) subjects showed significantly lower pSEV. Moreover, levels of state and trait anxiety were higher in HR children (F1=5.429, p=.021). Discussion: In our sample, measurement of pSEV allowed discrimination between children at high and low risk for PD. Since these results argue for possible alterations of saccadic function in high risk subjects, differences in underlying neurobiological mechanisms might be discussed as a possible endophenotype of PD.Export Options
About this article
Cite this article as:
Zwanzger Peter, Bradwejn Jacques, Diemer Julia, W. Marshall Roger and Koszycki Diana, Differences in Saccadic Eye Movements in Subjects at High and Low Risk for Panic Disorder, Current Pharmaceutical Design 2012; 18 (35) . https://dx.doi.org/10.2174/138161212803530934
DOI https://dx.doi.org/10.2174/138161212803530934 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Tuberculosis Prevention, Diagnosis and Drug Discovery"
The Nobel Prize-winning discoveries of Mycobacterium tuberculosis and streptomycin have enabled an appropriate diagnosis and an effective treatment of tuberculosis (TB). Since then, many newer diagnosis methods and drugs have been saving millions of lives. Despite advances in the past, TB is still a leading cause of infectious disease mortality ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
Melanoma and Non-Melanoma Skin Cancer Treatment: Standard of Care and Recent Advances
In this thematic issue, we aim to provide a standard of care of the diagnosis and treatment of melanoma and non-melanoma skin cancer. The editor will invite authors from different countries who will write review articles of melanoma and non-melanoma skin cancers. The Diagnosis, Staging, Surgical Treatment, Non-Surgical Treatment all ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Gastrin-Releasing Peptide Receptors Regulate Proliferation of C6 Glioma Cells through a Phosphatidylinositol 3-Kinase-Dependent Mechanism
Current Neurovascular Research Chronic Cerebrospinal Venous Insufficiency (CCSVI) and Multiple Sclerosis (MS): A Critical Review
CNS & Neurological Disorders - Drug Targets Development of Gel-Core Solid Lipid Nanoparticles as Drug Delivery Systems for Hydrophilic Molecules
Current Nanoscience Therapeutic Use of Chemokines
Current Pharmaceutical Design Dual Acting Isatin-heterocyclic Hybrids: Recent Highlights as Promising Pharmacological Agents
Letters in Drug Design & Discovery Preliminary Pharmacological Screening of Some Thiosemicarbazide, s-triazole, and Thiadiazole Derivatives
CNS & Neurological Disorders - Drug Targets Endoplasmic Reticulum Stress as a Novel Therapeutic Target in Heart Diseases
Cardiovascular & Hematological Disorders-Drug Targets The Role of Natural Killer T Cells in Atherosclerosis
Current Immunology Reviews (Discontinued) Polyunsaturated Fatty Acids in Pregnancy and Metabolic Syndrome: A Review
Current Pharmaceutical Biotechnology The PKB/AKT Pathway in Cancer
Current Pharmaceutical Design Genetic Studies on the Role of T-Type Ca2+ Channels in Sleep and Absence Epilepsy
CNS & Neurological Disorders - Drug Targets Spectral Methods of Characterizing the Conformational Changes of Glycated Goat Liver Cystatin
Current Proteomics P-Glycoprotein and Breast Cancer Resistance Protein Affect Disposition of Tandutinib, A Tyrosine Kinase Inhibitor
Drug Metabolism Letters Specific and Sensitive RP-HPLC Method Development and Validation for the Determination of Aripiprazole: Application in Preformulation Screening of Nanoemulsion
Current Nanomedicine Antibody-directed Double Suicide Gene Therapy Targeting of MUC1- Positive Leukemia Cells In Vitro and In Vivo
Current Gene Therapy Neutrophils and Eosinophils: Clinical Implications of their Appearance, Presence and Disappearance in Asthma and COPD
Current Drug Targets - Inflammation & Allergy Chemokine-Chemokine Receptor Network in Immune Cell Trafficking
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Role of Brain NUCB2/nesfatin-1 in the Stress-induced Modulation of Gastrointestinal Functions
Current Neuropharmacology A New Perspective on Probing the Interaction of Nicotine with Human Serum Albumin
Current Analytical Chemistry Local Recurrence vs Radiotherapy-Induced Edema in Advanced Laryngeal Carcinoma: Is FDG PET/CT Up to the Challenge?
Current Molecular Imaging (Discontinued)